| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $24.9M | -26.0% |
| SG&A Expense | $12.8M | +13.1% |
| Operating Income | -$37.7M | +16.2% |
| Pre-tax Income | -$39.6M | +23.8% |
| Income Tax | $0 | — |
| Net Income | -$39.6M | +23.8% |
| EPS (Basic) | -$2.58 | +39.3% |
| EPS (Diluted) | -$2.58 | +39.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.6M | +5.4% |
| Current Assets | $19.3M | -6.7% |
| Total Assets | $25.9M | -8.2% |
| Current Liabilities | $8.1M | -29.6% |
| Long-term Debt | $10.0M | -50.1% |
| Total Liabilities | $24.2M | -38.7% |
| Stockholders' Equity | $1.6M | +114.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.0M | +0.3% |
| Capital Expenditures | $16K | -81.6% |
| Investing Cash Flow | -$16K | +81.0% |
| Financing Cash Flow | $36.7M | -13.3% |
| Free Cash Flow | -$37.0M | +0.5% |